AB
INFI

Amalgamated Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Amalgamated Bank’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,875
Closed -$16K – 3277
2022
Q1 		$16K Sell
13,875
-1,168
-8% -$1.4K ﹤0.01% 2868
2021
Q4 		$34K Sell
15,043
-527
-3% -$1.32K ﹤0.01% 2129
2021
Q3 		$53K Sell
15,570
-535
-3% -$1.65K ﹤0.01% 2128
2021
Q2 		$48K Buy
+16,105
New +$51K ﹤0.01% 2167

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amalgamated Bank's INFI Position: Q2 2022 in Review

Amalgamated Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 13,875 shares — an estimated $16K sold.

Amalgamated Bank first reported a position in INFI in Q2 2021 and held it in 4 quarters. The position peaked at $53K in Q3 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • Amalgamated Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 13,875 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $16K.
  • Amalgamated Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2021 and held it in 4 quarters.
  • Amalgamated Bank's Infinity Pharmaceuticals, Inc. position peaked at $53K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.